Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

BTS Group - Europe recovered in Q3

08 november 2024

<a id="bm-comp-36d38c79-6aaa-4707-9e59-a38b86e8a23f" name="bm-comp-36d38c79-6aaa-4707-9e59-a38b86e8a23f" class="BMCustomAnchor"></a><table><tr><td bm-component-id="36d38c79-6aaa-4707-9e59-a38b86e8a23f" style="vertical-align: top; width:100.000000%;"><ul><li>Adj. EBITA -9% vs ABG and -26% vs cons (one large outlier)</li><li>5% organic growth (ABG 8%) vs 1% in Q2 and growth in all regions</li><li>FY guidance unchanged, estimates and share neutral to slightly down</li></ul></td></tr></table><a id="bm-comp-17b5c5ea-4146-4da9-be1c-360619c6d567" name="bm-comp-17b5c5ea-4146-4da9-be1c-360619c6d567" class="BMCustomAnchor"></a><table><tr><td bm-component-id="17b5c5ea-4146-4da9-be1c-360619c6d567" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Q3 details</h3><p>Sales SEK 657m (-3% vs ABG 676m, -3% vs cons 677m), adj. EBITA 60m (-9% vs ABG 66m, -26% vs cons 81m), adj. EBITA margin 9.2% (ABG 9.8%, cons 11.9%). FX adj growth 8% (vs ABG 10%). Net income was positively affected by a SEK 166m reversed earn-out for the Netmind acquisition, explaining the EPS beat.</p><h3 class="bm-h3">Europe recovered as promised</h3><p>European sales grew 5% in Q3, up from -23% in Q2 and in line with previous communication of low-single digit recovery in H2. North America slowed somewhat to 6% growth amid some hesitant customers likely awaiting the US election outcome, while Rest of World grew 16%. One consensus estimate outlier on the upside, so we put little emphasis on the large deviation to cons. The SEK 7m EBITA miss vs us in Other markets mainly explained the group deviation on EBITA of SEK 6m. BTS reiterates FY guidance of &#8220;2024 EBITA will be better than 2023&#8221; as expected although some risks if Europe continued weak (cons has 11% EBITA growth, ABG 8%), which limits estimate revisions.</p><h3 class="bm-h3">Estimates and stock neutral to slightly down</h3><p>Consensus (adjusted for the outlier) likely to cut EBITA estimates by 2-3% but report pretty much as expected, and share should be neutral or just slightly down today. Conf call at CET 9.30.</p></td></tr></table><a id="bm-comp-c473cfb7-5c18-4cc9-8d49-90a9eb308267" name="bm-comp-c473cfb7-5c18-4cc9-8d49-90a9eb308267" class="BMCustomAnchor"></a><table><tr><td bm-component-id="c473cfb7-5c18-4cc9-8d49-90a9eb308267" style="vertical-align: top; width:100.000000%;"><table id="bm-img-cb046e7b-1609-4bb7-9df5-787c7c3b5f4f" class="bm-img-table xslt-img-empty xslt-img-include"><tr><td class="xslt-img-caption">Deviation</td></tr><tr><td><img bm-img-encrypt="cb046e7b-1609-4bb7-9df5-787c7c3b5f4f" bm-img-original-height="1052" bm-img-original-width="784" bm-img-svg="image:image_upload/83181_a715bb48-043e-4272-a376-bd05c1d2bdbb.svg" bm-img-width-hint="71.80%" id="bm-id-cb046e7b-1609-4bb7-9df5-787c7c3b5f4f" src="https://abgsc.bluematrix.com/images/image_upload/83181_a715bb48-043e-4272-a376-bd05c1d2bdbb_522.png" svg="/nas/web/clients/abgsc/images/image_upload/83181_a715bb48-043e-4272-a376-bd05c1d2bdbb.svg" width="522" alt="" title="" /></td></tr><tr><td class="xslt-img-source">Source: ABG Sundal Collier, FactSet consensus, company data</td></tr></table></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2025-11-10 Cavotec - Waiting for the order engine to turn Cavotec Analys
2025-11-10 Infrea - Execution paves the way forward Infrea Analys
2025-11-09 Formpipe - Public divestment changes the outlook Formpipe Analys
2025-11-07 Inission - The trough is behind us Inission Analys
2025-11-07 Clavister - Improving margins backed by cost control Clavister Analys
2025-11-07 Infrea - A quarter in the right direction Infrea Analys
2025-11-07 Cavotec - Short-term softness from project timing Cavotec Analys
2025-11-07 Inission - Inission much better y-o-y, Enedo hold... Inission Analys
2025-11-06 Viscaria - Filling the coffers Viscaria Analys
2025-11-06 NYAB - Solid margin resilience amid strong growth NYAB Analys
2025-11-06 G5 Entertainment - Finally, better growth momentum G5 Entertai.. Analys
2025-11-06 Arctic Paper - Strong paper Arctic Paper Analys
2025-11-06 Clavister - In line with pre-announcement Clavister Analys
2025-11-05 Ascelia Pharma - Continuing to position itself fo... Ascelia Pharma Analys
2025-11-05 Bredband2 - ARPU gains outweigh churn pains Bredband2 Analys
2025-11-05 OrganoClick - Cost savings to cushion volume head... OrganoClick Analys
2025-11-05 Medicover - Execution remains solid Medicover Analys
2025-11-05 SinterCast - Market headwinds in '25, set for gro... SinterCast Analys
2025-11-05 OrganoClick - Challenging Q3, but cost-cutting un... OrganoClick Analys
2025-11-05 G5 Entertainment - Guides for accelerated growth ... G5 Entertai.. Analys